|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | C07C 235/60 | (2006.01) |
| C07D 213/81 | (2006.01) | ||
| C07C 237/42 | (2006.01) | ||
| C07C 255/57 | (2006.01) |
| (11) | Number of the document | 2044005 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07835890.0 |
| Date of filing the European patent application | 2007-06-26 | |
| (97) | Date of publication of the European application | 2009-04-08 |
| (45) | Date of publication and mention of the grant of the patent | 2010-10-20 |
| (46) | Date of publication of the claims translation | 2011-04-26 |
| (86) | Number | PCT/US2007/014832 |
| Date | 2007-06-26 |
| (87) | Number | WO 2008/002576 |
| Date | 2008-01-03 |
| (30) | Number | Date | Country code |
| 816522 P | 2006-06-26 | US |
| (72) |
KAWAMOTO, Richard Masaru, US
WARSHAKOON, Namal, Chithranga, US
EVDOKIMOV, Artem, G., US
WU, Shengde, US
BOYER, Angelique, Sun, US
GREIS, Kenneth, Donald, US
|
| (73) |
Akebia Therapeutics Inc.,
245 First Street, Suite 1100, Cambridge, MA 02142,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Prolilhidroksilazės inhibitoriai ir jų panaudojimo būdai |
| PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USE |
| Payment date | Validity (years) | Amount | |
| 2017-05-18 | 11 | 289.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2018-03-24 |